Rare diseases
Investigational molecules
Locations
Study on the Effectiveness and Safety of Sparsentan and Dapagliflozin for Patients with Immunoglobulin A Nephropathy (IgAN)
BelgiumStudy on the Effects of Inhaled Treprostinil for Patients with Idiopathic Pulmonary Fibrosis
BelgiumStudy of Nous-209 Genetic Vaccine and Pembrolizumab for Patients with Advanced Microsatellite Instability-High Colorectal Cancer
BelgiumStudy Comparing Chemotherapy with Paclitaxel, Ifosfamide, and Cisplatin versus High-Dose Chemotherapy with Paclitaxel and Drug Combination for Relapsed Germ Cell Tumors
BelgiumStudy on Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
BelgiumStudy on JDQ443 for First-Line Treatment in Patients with Advanced KRAS G12C-Mutated Non-Small Cell Lung Cancer
BelgiumStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
BelgiumStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
BelgiumStudy of Sotatercept for Patients with Severe Pulmonary Arterial Hypertension at High Risk of Mortality
BelgiumStudy Comparing Radiotherapy Alone to Radiotherapy with Cisplatin for Patients with Sinus or Salivary Gland Tumors
BelgiumStudy of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer
BelgiumStudy of Exagamglogene Autotemcel (CTX001) for Treatment of Severe Sickle Cell Disease Using Modified Stem Cells
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
